POU4F1 (POU class 4 homeobox 1) is a transcription factor that functions as both an activator and repressor of RNA polymerase II-dependent gene expression 1. While classically characterized as a neuronal development regulator involved in trigeminal nerve and peripheral nervous system neuron development [GO annotations], recent evidence reveals unexpected roles in diverse pathological contexts. Mechanistically, POU4F1 acts as a Smad3 target gene that regulates macrophage-myofibroblast transition by controlling fibrogenic gene networks downstream of TGF-β1/Smad3 signaling 2. In cancer, POU4F1 directly binds CDK2 and CCND1 promoters to promote G1/S transition in basal-like breast cancer 1, while in melanoma it enhances glycolysis via METTL1-mediated m7G methylation of PKM2, promoting anti-PD-1 resistance 3. POU4F1 also functions as a transcription factor for STAT3, facilitating glioma cell pyroptosis when downregulated 4. Disease relevance extends beyond its known association with childhood-onset ataxia, intention tremor, and hypotonia syndrome to include renal fibrosis, breast cancer malignancy, melanoma immunotherapy resistance, and glioma progression. In Hirschsprung disease, USP46-stabilized POU4F1 promotes neural cell migration through HPSE-mediated extracellular matrix remodeling 5. The POU4F1 locus is also dysregulated in t(8;21) acute myeloid leukemia 6. However, POU4F1 polymorphisms show no association with normal-tension glaucoma susceptibility 7, suggesting disease-context specificity.